• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.27% Nasdaq Down 0.19%

    More On HIK.L

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Hikma Pharmaceuticals PLC (HIK.L)

    -LSE
    2,385.00 Down 4.00(0.17%) Aug 4
    Add to Portfolio
    Prev Close:2,385.00
    Open:2,389.00
    Bid:2,384.00
    Ask:2,386.00
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:2,373.00 - 2,402.00
    52wk Range:1,580.00 - 2,617.00
    Volume:295,535
    Avg Vol (3m):357,235
    Market Cap:4.74B
    P/E (ttm):1,715.83
    EPS (ttm):1.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in GBp.

    Key Statistics

    Forward P/E (1 yr):14.91
    P/S (ttm):318.09
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.37
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.32

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, Europe... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback